Protective action of SP600125,an inhibitor of c-Jun N-terminalk inase on hippocampal CA1 neuron in amygdala kindled epilepsy rats

liu ping,liu hongchao,wang baofeng,tan yihu,wu jun,chen xu,shu kai
DOI: https://doi.org/10.7683/xxyxyxb.2014.11.006
2014-01-01
Abstract:Objective To explore the protective action of SP600125,an inhibitor of c-Jun N-terminalk inase(JNK) on hippocampal CA1 neuron in amygdala kindled rats. Methods Thirty health male Wistar rats were randomly divided into kindling group,medicine group and medicine control group,ten rats in each group. The brain tissue was obtained by perfusion after ten times epileptic seizure. Westem blotting was used to detect the expression of JNK and phosphorylation of JNK( p-JNK).Pathological changes of the hippocampus were observed by glial fibrillary acidic protein(GFAP) staining and Nissl staining and the results were compared in each group. Results The level of JNK phosphorylation in the hippocampus in the medicine group(0.347 ±0.033) was significantly lower than that in the kindling group(0. 510 ± 0. 039) and the medicine control group(0.476 ±0.045)(P <0.05). There were no statistic difference of the levels of total JNK in each group(P >0.05). The positive cells of GFAP in medicine group(42. 27 ± 4. 63) were significantly lower than those in the kindling group(68. 82 ±5. 36)and the medicine control group(69. 06 ± 4. 63)(P < 0. 05). Nissl staining showed that the number of normal neuron in the medicine group(37. 82 ± 6. 30) was significantly higher than that in the kindling group(19. 87 ± 3. 58) and the medicine control group(20. 13 ± 5. 37)(P < 0. 05). Conclusion SP600125,a specific inhibitor of JNK,has a protective effect on neurons in hippocampal CA1 region in amygdala kindled model rats. SP600125 may be a new and effective strategy to treat temporal lobe epilepsy by suppressing the activation of JNK.
What problem does this paper attempt to address?